Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
Authors
Keywords
-
Journal
Molecular Therapy-Nucleic Acids
Volume 32, Issue -, Pages 758-772
Publisher
Elsevier BV
Online
2023-05-09
DOI
10.1016/j.omtn.2023.05.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of DNA aptamers that specifically targets EBV+ nasopharyngeal carcinoma via binding with EphA2/CD98hc complex
- (2022) Yaqi Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
- (2022) Macarena Hernández-Jiménez et al. Molecular Therapy-Nucleic Acids
- Drug conjugate-based anticancer therapy - Current status and perspectives
- (2022) Yuqi Yang et al. CANCER LETTERS
- Oncogenic functions and therapeutic targeting of EphA2 in cancer
- (2021) Kalin Wilson et al. ONCOGENE
- Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
- (2021) Yao Zhao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer
- (2021) Xixun Zhang Frontiers in Oncology
- Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy
- (2021) Yaqi Yang et al. Bioengineered
- EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma
- (2021) Giorgia Giordano et al. Cells
- Targeting Ephrin Receptor Tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells
- (2020) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- 613PPhase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer
- (2019) N Halama et al. ANNALS OF ONCOLOGY
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
- (2018) Silvia Garcia-Monclús et al. INTERNATIONAL JOURNAL OF CANCER
- Aptamer Therapeutics in Cancer: Current and Future
- (2018) Yoshihiro Morita et al. Cancers
- Analyzing HT-SELEX data with the Galaxy Project tools – A web based bioinformatics platform for biomedical research
- (2016) William H. Thiel et al. METHODS
- EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
- (2015) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
- (2014) Hongguang Sun et al. Molecular Therapy-Nucleic Acids
- Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
- (2013) J PosthumaDeBoer et al. BRITISH JOURNAL OF CANCER
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
- (2012) Kristina W. Thiel et al. NUCLEIC ACIDS RESEARCH
- Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection
- (2012) William H. Thiel et al. PLoS One
- ViennaRNA Package 2.0
- (2011) Ronny Lorenz et al. Algorithms for Molecular Biology
- EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
- (2011) RONG Biao-xue et al. CURRENT CANCER DRUG TARGETS
- Epha2 is a critical oncogene in melanoma
- (2011) D Udayakumar et al. ONCOGENE
- EphA2 as a promoter of melanoma tumorigenicity
- (2010) Naira V. Margaryan et al. CANCER BIOLOGY & THERAPY
- Aptamers as a model for functional evaluation of LNA and 2′-amino LNA
- (2009) Frank J. Hernandez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
- (2009) Hui Miao et al. CANCER CELL
- Label free optical sensor for Avidin based on single gold nanoparticles functionalized with aptamers
- (2009) Frank Jeyson Hernandez et al. Journal of Biophotonics
- A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo
- (2008) D. Jackson et al. CANCER RESEARCH
- Interleukin-13 Receptor 2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
- (2008) J. Wykosky et al. CLINICAL CANCER RESEARCH
- The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
- (2008) Dana M. Brantley-Sieders et al. JOURNAL OF CLINICAL INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started